Inventor · Laarne, BE

Erik Depla

45Patents
7h-index
64Co-inventors
72Inventor score

Filing activity: Jul 23, 1999 → Oct 5, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7101561B2 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use Chemistry; Metallurgy 16 Expired
US7238356B2 Core-glycosylated HCV envelope proteins Chemistry; Metallurgy 14 Expired
US9193780B2 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases Chemistry; Metallurgy 14 Active
US6635257B1 Particles of HCV envelope proteins: use for vaccination Emerging Cross-Sectional Technologies 10 Expired
US9527925B2 Bispecific binding molecules binding to VEGF and ANG2 Chemistry; Metallurgy 9 Active
US7048930B2 Expression of core-glycosylated HCV envelope proteins in yeast Chemistry; Metallurgy 9 Expired
US8945567B2 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections Chemistry; Metallurgy 7 Active
US9834595B2 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases Chemistry; Metallurgy 5 Active
US10550174B2 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases Chemistry; Metallurgy 5 Active
US7314925B2 Constructs and methods for expression of recombinant HCV envelope proteins Chemistry; Metallurgy 5 Expired
US9713589B2 Methods and compositions for the preparation of aerosols Human Necessities 4 Active
US9644022B2 Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections Chemistry; Metallurgy 4 Active
US9803001B2 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections Chemistry; Metallurgy 4 Active
US9035029B2 CX3CR1-binding polypeptides comprising immunoglobulin single variable domains Chemistry; Metallurgy 4 Active
US9320792B2 Pulmonary administration of immunoglobulin single variable domains and constructs thereof Chemistry; Metallurgy 3 Active
US6670114B1 Host derived proteins binding HCV: medical, diagnostic and purification use Physics 3 Expired
US10385134B2 CX3CR1-binding polypeptides comprising immunoglobulin single variable domains Chemistry; Metallurgy 3 Active
US9458235B2 Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides Chemistry; Metallurgy 2 Active
US7413741B2 HCV E1 comprising specific disulfide bridges Chemistry; Metallurgy 2 Active
US6521403B1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue Chemistry; Metallurgy 2 Expired
US9783612B2 CX3CR1-binding polypeptides Chemistry; Metallurgy 2 Active
US10414828B2 Bispecific binding molecules binding to VEGF and Ang2 Chemistry; Metallurgy 2 Active
US9725522B2 Pulmonary administration of immunoglobulin single variable domains and constructs thereof Chemistry; Metallurgy 2 Active
US11384151B2 CX3CR1-binding polypeptides comprising immunoglobulin single variable domains Chemistry; Metallurgy 1 Active
US11161916B2 Bispecific binding molecules binding to VEGF and Ang2 Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.